Post-effective amendment to a registration statement that is not immediately effective upon filing

Related Party Transactions (Details)

v3.22.1
Related Party Transactions (Details) - USD ($)
$ in Thousands
12 Months Ended
Jul. 26, 2021
Dec. 31, 2021
Dec. 31, 2020
Related Party Transaction [Line Items]      
Accounts payable due to related parties   $ 100 $ 100
Common stock issued   9,624 2,579
CEO      
Related Party Transaction [Line Items]      
Compensation amount received related to related party transaction   400 500
PillTracker SOW      
Related Party Transaction [Line Items]      
Payment to related party   1,000 300
Total cost under SOW $ 200    
Pilltracker STO [Member]      
Related Party Transaction [Line Items]      
Supplemental Task Order expected costs   400  
Neuro Rx [Member] | Chief Commercial Officer [Member]      
Related Party Transaction [Line Items]      
Payment to related party   100 100
Neuro Rx [Member] | Glytech Agreement [Member]      
Related Party Transaction [Line Items]      
Continuing technology support services and reimbursed expenses   $ 300 $ 300
Related party transaction description   The Excluded Technology will transfer to the Company for no additional consideration if aggregate the value of NRx Pharmaceuticals equity held by Glytech exceeds $50.0 million on any date prior to August 6, 2022, based on the average daily value of the equity held by Glytech during a period of 20 consecutive days prior to such date.